-
1
-
-
0028232269
-
Chemopreventive drug development: Perspectives and progress
-
Kelloff, G. J., Boone, C. W., Crowell, J. A., Steele, V. E., Lubet, R., and Sigman, C. C. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol., Biomarkers & Prev., 3: 85-98.
-
Cancer Epidemiol., Biomarkers & Prev.
, vol.3
, pp. 85-98
-
-
Kelloff, G.J.1
Boone, C.W.2
Crowell, J.A.3
Steele, V.E.4
Lubet, R.5
Sigman, C.C.6
-
2
-
-
0028700516
-
Mechanistic considerations in chemopreventive drug development
-
Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., Lubet, R. A., Crowell, J. A., and Sigman, C. C. Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem., Suppl., 20: 1-24, 1994.
-
(1994)
J. Cell. Biochem., Suppl.
, vol.20
, pp. 1-24
-
-
Kelloff, G.J.1
Boone, C.W.2
Steele, V.E.3
Fay, J.R.4
Lubet, R.A.5
Crowell, J.A.6
Sigman, C.C.7
-
3
-
-
0012791002
-
Inhibition of chemical carcinogenesis
-
J. Arcos, M. Argus, and Y. Woo (eds.), Boston: Birkhäuser Boston, Inc.
-
Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., and Sigman, C. C. Inhibition of chemical carcinogenesis. In: J. Arcos, M. Argus, and Y. Woo (eds.), Chemical Induction of Cancer: Modulation and Combination Effects, pp. 73-122. Boston: Birkhäuser Boston, Inc., 1995.
-
(1995)
Chemical Induction of Cancer: Modulation and Combination Effects
, pp. 73-122
-
-
Kelloff, G.J.1
Boone, C.W.2
Steele, V.E.3
Fay, J.R.4
Sigman, C.C.5
-
4
-
-
0029328342
-
Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
-
Karin, M., and Hunter, T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol., 5: 747-757, 1995.
-
(1995)
Curr. Biol.
, vol.5
, pp. 747-757
-
-
Karin, M.1
Hunter, T.2
-
5
-
-
0028897113
-
Transcriptional regulation by extracellular signals: Mechanisms and specificity
-
Hill, C. S., and Treisman, R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell, 80: 199-211, 1995.
-
(1995)
Cell
, vol.80
, pp. 199-211
-
-
Hill, C.S.1
Treisman, R.2
-
6
-
-
0342748236
-
Oncogenes and growth factors
-
Chap. 11, Boston: Jones and Bartlett Publishers
-
Cooper, G. M. Oncogenes and growth factors. In: Oncogenes, Chap. 11, pp. 163-173, Boston: Jones and Bartlett Publishers, 1990.
-
(1990)
Oncogenes
, pp. 163-173
-
-
Cooper, G.M.1
-
7
-
-
0026454471
-
Protein-tyrosine kinase inhibition: Mechanism-based discovery of antitumor agents
-
Lloydia
-
Chang, C-J., and Geahlen, R. L. Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. J. Nat. Prod. (Lloydia), 55: 1529-1560, 1992.
-
(1992)
J. Nat. Prod.
, vol.55
, pp. 1529-1560
-
-
Chang, C.-J.1
Geahlen, R.L.2
-
8
-
-
0028069064
-
Signalling pathways as targets for anticancer drug development
-
Powis, G. Signalling pathways as targets for anticancer drug development. Pharmacol. & Ther., 62: 57-95, 1994.
-
(1994)
Pharmacol. & Ther.
, vol.62
, pp. 57-95
-
-
Powis, G.1
-
9
-
-
0028017791
-
Signalling targets for the development of cancer drugs
-
Powis, G., and Workman, P. Signalling targets for the development of cancer drugs. Anti-Cancer Drug Des., 9: 263-277, 1994.
-
(1994)
Anti-Cancer Drug Des.
, vol.9
, pp. 263-277
-
-
Powis, G.1
Workman, P.2
-
10
-
-
0028968949
-
Tyrosine kinase inhibition: An approach to drug development
-
Washington DC
-
Levitzki, A., and Gazit, A. Tyrosine kinase inhibition: an approach to drug development. Science (Washington DC), 267: 1782-1788, 1995.
-
(1995)
Science
, vol.267
, pp. 1782-1788
-
-
Levitzki, A.1
Gazit, A.2
-
11
-
-
0028292482
-
Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis
-
Shin, D. M., Ro, J. Y., Hong, W. K., and Hittelman, W. N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 3153-3159, 1994.
-
(1994)
Cancer Res.
, vol.54
, pp. 3153-3159
-
-
Shin, D.M.1
Ro, J.Y.2
Hong, W.K.3
Hittelman, W.N.4
-
12
-
-
0028000069
-
Signal-transduction therapy. A novel approach to disease management
-
Levitzki, A. Signal-transduction therapy. A novel approach to disease management. Eur. J. Biochem., 226: 1-13, 1994.
-
(1994)
Eur. J. Biochem.
, vol.226
, pp. 1-13
-
-
Levitzki, A.1
-
13
-
-
0026028343
-
Prevalence of aberrant expression of the epidermal growth factor receptors in human cancers
-
Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptors in human cancers. Br. Med. Bull., 47: 87-98, 1991.
-
(1991)
Br. Med. Bull.
, vol.47
, pp. 87-98
-
-
Gullick, W.J.1
-
14
-
-
0028955388
-
Epidermal growth factor-related peptides and their receptors in human malignancies
-
Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
-
(1995)
Crit. Rev. Oncol. Hematol.
, vol.19
, pp. 183-232
-
-
Salomon, D.S.1
Brandt, R.2
Ciardiello, F.3
Normanno, N.4
-
15
-
-
0029099375
-
Transforming growth factor α
-
Kumar, V., Bustin, S. A., and McKay, I. A. Transforming growth factor α. Cell Biol. Int., 19: 373-388, 1995.
-
(1995)
Cell Biol. Int.
, vol.19
, pp. 373-388
-
-
Kumar, V.1
Bustin, S.A.2
McKay, I.A.3
-
16
-
-
0029017926
-
Transforming growth factor α: Expression, regulation, and biological activities
-
Lee, D. C., Fenton, S. E., Berkowitz, E. A., and Hissong, M. A. Transforming growth factor α: expression, regulation, and biological activities. Pharmacol. Rev., 47: 51-85, 1995.
-
(1995)
Pharmacol. Rev.
, vol.47
, pp. 51-85
-
-
Lee, D.C.1
Fenton, S.E.2
Berkowitz, E.A.3
Hissong, M.A.4
-
17
-
-
0028874191
-
The role of amphiregulin in breast cancer
-
Salomon, D. S., Normanno, N., Ciardiello, F., Brandt, R., Shoyab, M., and Todaro, G. J. The role of amphiregulin in breast cancer. Breast Cancer Res. Treat., 33: 103-114, 1995.
-
(1995)
Breast Cancer Res. Treat.
, vol.33
, pp. 103-114
-
-
Salomon, D.S.1
Normanno, N.2
Ciardiello, F.3
Brandt, R.4
Shoyab, M.5
Todaro, G.J.6
-
18
-
-
0029124144
-
The epidermal growth factor
-
Boonstra, J., Rijken, P., Humbel, B., Cremers, F., Verkleij, A., and van Bergen-Henegouwen, P. The epidermal growth factor. Cell Biol. Int., 19: 413-430, 1995.
-
(1995)
Cell Biol. Int.
, vol.19
, pp. 413-430
-
-
Boonstra, J.1
Rijken, P.2
Humbel, B.3
Cremers, F.4
Verkleij, A.5
Van Bergen-Henegouwen, P.6
-
19
-
-
0029025036
-
The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors
-
Malarkey, K., Belham, C. M., Paul, A., Graham, A., McLees, A., Scott, P. H., and Plevin, R. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem. J., 309: 361-375, 1995.
-
(1995)
Biochem. J.
, vol.309
, pp. 361-375
-
-
Malarkey, K.1
Belham, C.M.2
Paul, A.3
Graham, A.4
McLees, A.5
Scott, P.H.6
Plevin, R.7
-
20
-
-
0028538304
-
Just another signalling pathway
-
Briscoe, J., Guschin, D., and Muller, M. Just another signalling pathway. Curr. Biol., 4: 1033-1035, 1994.
-
(1994)
Curr. Biol.
, vol.4
, pp. 1033-1035
-
-
Briscoe, J.1
Guschin, D.2
Muller, M.3
-
21
-
-
0028237507
-
Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
-
Ekstrand, A. J., Longo, N., Hamid, M. L., Olson, J. L., Liu, L., Collins, V. P., and James, C. D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene, 9: 2313-2320, 1994.
-
(1994)
Oncogene
, vol.9
, pp. 2313-2320
-
-
Ekstrand, A.J.1
Longo, N.2
Hamid, M.L.3
Olson, J.L.4
Liu, L.5
Collins, V.P.6
James, C.D.7
-
22
-
-
0028927012
-
Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor
-
Ekstrand, A. J., Liu, L., He, J., Hamid, M. L., Longo, N., Collins, V. P., and James, C. D. Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor. Oncogene, 10: 1455-1460, 1995.
-
(1995)
Oncogene
, vol.10
, pp. 1455-1460
-
-
Ekstrand, A.J.1
Liu, L.2
He, J.3
Hamid, M.L.4
Longo, N.5
Collins, V.P.6
James, C.D.7
-
23
-
-
0028146767
-
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
-
Nishikawa, R., Ji, X-D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Huang, H-J. S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727-7731.
-
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 7727-7731
-
-
Nishikawa, R.1
Ji, X.-D.2
Harmon, R.C.3
Lazar, C.S.4
Gill, G.N.5
Cavenee, W.K.6
Huang, H.-J.S.7
-
24
-
-
0027225697
-
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas
-
Garcia de Palazzo, I. E., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., and Weiner, L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53: 3217-3220, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 3217-3220
-
-
Garcia De Palazzo, I.E.1
Adams, G.P.2
Sundareshan, P.3
Wong, A.J.4
Testa, J.R.5
Bigner, D.D.6
Weiner, L.M.7
-
25
-
-
0029025332
-
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
-
Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Mostacello, D., Pegram, C. N., Reist, C. J., Traweek, S. T., Wong, A. J., Zalutsky, M. R., and Bigner, D. D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 3140-3148
-
-
Wikstrand, C.J.1
Hale, L.P.2
Batra, S.K.3
Hill, M.L.4
Humphrey, P.A.5
Kurpad, S.N.6
McLendon, R.E.7
Mostacello, D.8
Pegram, C.N.9
Reist, C.J.10
Traweek, S.T.11
Wong, A.J.12
Zalutsky, M.R.13
Bigner, D.D.14
-
26
-
-
0028800035
-
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
-
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L., and Wong, A. J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res., 55: 5536-5539, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 5536-5539
-
-
Moscatello, D.K.1
Holgado-Madruga, M.2
Godwin, A.K.3
Ramirez, G.4
Gunn, G.5
Zoltick, P.W.6
Biegel, J.A.7
Hayes, R.L.8
Wong, A.J.9
-
27
-
-
0028323719
-
Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor
-
Carter, T. H., and Kung, H. J. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit. Rev. Oncog., 5: 389-428, 1994.
-
(1994)
Crit. Rev. Oncog.
, vol.5
, pp. 389-428
-
-
Carter, T.H.1
Kung, H.J.2
-
28
-
-
0028237504
-
Potent SUC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites
-
Soler, C., Alvarez, C. V., Beguinot, L., and Carpenter, G. Potent SUC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Oncogene, 9: 2207-2215, 1994.
-
(1994)
Oncogene
, vol.9
, pp. 2207-2215
-
-
Soler, C.1
Alvarez, C.V.2
Beguinot, L.3
Carpenter, G.4
-
29
-
-
0025341727
-
TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas
-
Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., and Merlino, G. T. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61: 1137-1146, 1990.
-
(1990)
Cell
, vol.61
, pp. 1137-1146
-
-
Jhappan, C.1
Stahle, C.2
Harkins, R.N.3
Fausto, N.4
Smith, G.H.5
Merlino, G.T.6
-
30
-
-
0025297086
-
Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
-
Sandgren, E. P., Luetteke, N. C, Palmiter, R. D., Brinster, R. L., and Lee, D. C. Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell, 61: 1121, 1990.
-
(1990)
Cell
, vol.61
, pp. 1121
-
-
Sandgren, E.P.1
Luetteke, N.C.2
Palmiter, R.D.3
Brinster, R.L.4
Lee, D.C.5
-
31
-
-
0027245446
-
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor α in hepatic oncogenesis
-
Murakami, H., Sanderson, N. D., Nagy, P., Marino, P. A., Merlino, G., and Thorgiersson, S. S. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res., 53: 1719-1723, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 1719-1723
-
-
Murakami, H.1
Sanderson, N.D.2
Nagy, P.3
Marino, P.A.4
Merlino, G.5
Thorgiersson, S.S.6
-
32
-
-
0027454943
-
Transforming growth factor α dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver
-
Sandgren, E. P., Luetteke, N. C., Qiu, T. H., Palmiter, R. D., Brinster, R. L., and Lee, D. C. Transforming growth factor α dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell. Biol., 13: 320-330, 1993.
-
(1993)
Mol. Cell. Biol.
, vol.13
, pp. 320-330
-
-
Sandgren, E.P.1
Luetteke, N.C.2
Qiu, T.H.3
Palmiter, R.D.4
Brinster, R.L.5
Lee, D.C.6
-
33
-
-
0027439694
-
Autocrine transforming growth factor α is associated with progression of transformed properties in human colon cancer cells
-
Ziober, B. L., Willson, J. K. V., Hymphrey, L. E., Childress-Fields, K., and Brattain, M. G. Autocrine transforming growth factor α is associated with progression of transformed properties in human colon cancer cells. J. Biol. Chem., 268: 691-698, 1993.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 691-698
-
-
Ziober, B.L.1
Willson, J.K.V.2
Hymphrey, L.E.3
Childress-Fields, K.4
Brattain, M.G.5
-
34
-
-
0022551229
-
Role of epidermal growth factor in carcinogenesis
-
Stoscheck, C. M., and King, L. E., Jr. Role of epidermal growth factor in carcinogenesis. Cancer Res., 46: 1030-1037, 1986.
-
(1986)
Cancer Res.
, vol.46
, pp. 1030-1037
-
-
Stoscheck, C.M.1
King Jr., L.E.2
-
35
-
-
0025737543
-
Altered regulation of TGFβ1 and TGFα in primary keratinocytes and papillomas expressing v-Ha-ras
-
Glick, A. B., Sporn, M. B., and Yuspa, S. H. Altered regulation of TGFβ1 and TGFα in primary keratinocytes and papillomas expressing v-Ha-ras. Mol. Carcinog., 4: 210-219, 1991.
-
(1991)
Mol. Carcinog.
, vol.4
, pp. 210-219
-
-
Glick, A.B.1
Sporn, M.B.2
Yuspa, S.H.3
-
36
-
-
0028962318
-
Autocrine transforming growth factor α is dispensable for v-rasHa-induced epidermal neoplasia: Potential involvement of alternate epidermal growth factor receptor ligands
-
Dlugosz, A. A., Cheng, C., Williams, E. K., Darwiche, N., Dempsey, P. J., Mann, B., Dunn, A. R., Coffey, R. J., Jr., and Yuspa, S. H. Autocrine transforming growth factor α is dispensable for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res., 55: 1883-1893, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 1883-1893
-
-
Dlugosz, A.A.1
Cheng, C.2
Williams, E.K.3
Darwiche, N.4
Dempsey, P.J.5
Mann, B.6
Dunn, A.R.7
Coffey Jr., R.J.8
Yuspa, S.H.9
-
37
-
-
0025234545
-
Biomarkers as intermediate end points in chemoprevention trials
-
Lippman, S. M., Lee, J. S., Lotan, R., Hittelman, W., Wargovich, M. J., and Hong, W. K. Biomarkers as intermediate end points in chemoprevention trials. J. Natl. Cancer Inst., 82: 555-560, 1990.
-
(1990)
J. Natl. Cancer Inst.
, vol.82
, pp. 555-560
-
-
Lippman, S.M.1
Lee, J.S.2
Lotan, R.3
Hittelman, W.4
Wargovich, M.J.5
Hong, W.K.6
-
38
-
-
0027350726
-
TGFα and EGFR in head and neck cancer
-
Grandis, J. R., and Tweardy, D. J. TGFα and EGFR in head and neck cancer. J. Cell. Biochem., 17F: 188-191, 1993.
-
(1993)
J. Cell. Biochem.
, vol.17 F
, pp. 188-191
-
-
Grandis, J.R.1
Tweardy, D.J.2
-
39
-
-
0024363095
-
The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer
-
Bergler, W., Bier, H., and Ganzer, U. The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer. Acta Oto-Rhino-Laryngol. Belg., 246: 121-125, 1989.
-
(1989)
Acta Oto-Rhino-Laryngol. Belg.
, vol.246
, pp. 121-125
-
-
Bergler, W.1
Bier, H.2
Ganzer, U.3
-
40
-
-
0025774584
-
Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy
-
Shirasuna, K., Hayashido, Y., Sugiyama, M., Yoshioka, H., and Matsuya, T. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy. Virchows Arch. A Pathol. Anat. Histopathol., 418: 349-353, 1991.
-
(1991)
Virchows Arch. A Pathol. Anat. Histopathol.
, vol.418
, pp. 349-353
-
-
Shirasuna, K.1
Hayashido, Y.2
Sugiyama, M.3
Yoshioka, H.4
Matsuya, T.5
-
41
-
-
0027487861
-
Recent advances in head and neck cancer - Larynx preservation and cancer chemoprevention: The Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture
-
Hong, W. K., Lippman, S. M., and Wolf, G. T. Recent advances in head and neck cancer - larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 53: 5113-5120, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 5113-5120
-
-
Hong, W.K.1
Lippman, S.M.2
Wolf, G.T.3
-
42
-
-
0024358116
-
Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck
-
Lippman, S. M., Garewal, H. S., and Meyskens, F. L. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev. Med., 18: 740-748, 1989.
-
(1989)
Prev. Med.
, vol.18
, pp. 740-748
-
-
Lippman, S.M.1
Garewal, H.S.2
Meyskens, F.L.3
-
43
-
-
0028708255
-
Retinoid modulation of biomarkers in oral leukoplakia/dysplasia
-
Beenken, S. W., Huang, P., Sellers, M., Peters, G., Listinsky, C., Stockard, C., Hubbard, W., Wheeler, R., and Grizzle, W. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia. J. Cell. Biochem., 19 (Suppl.): 270-277, 1994.
-
(1994)
J. Cell. Biochem.
, vol.19
, Issue.SUPPL.
, pp. 270-277
-
-
Beenken, S.W.1
Huang, P.2
Sellers, M.3
Peters, G.4
Listinsky, C.5
Stockard, C.6
Hubbard, W.7
Wheeler, R.8
Grizzle, W.9
-
44
-
-
0028433383
-
Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesion of human bronchus
-
Yoneda, K. Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesion of human bronchus. Mod. Pathol., 7: 480-486, 1994.
-
(1994)
Mod. Pathol.
, vol.7
, pp. 480-486
-
-
Yoneda, K.1
-
45
-
-
0028913802
-
Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia, and coexpression precedes squamous cell carcinoma development
-
Rusch, V., Klimstra, D., Linkov, I., and Dmitrovsky, E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia, and coexpression precedes squamous cell carcinoma development. Cancer Res., 55: 1365-1372, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 1365-1372
-
-
Rusch, V.1
Klimstra, D.2
Linkov, I.3
Dmitrovsky, E.4
-
46
-
-
0026599255
-
Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma
-
Jankowski, J., Hopwood, D., and Wormsley, K. G. Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand. J. Gastroenterol., 27: 147-154, 1992.
-
(1992)
Scand. J. Gastroenterol.
, vol.27
, pp. 147-154
-
-
Jankowski, J.1
Hopwood, D.2
Wormsley, K.G.3
-
47
-
-
0026593881
-
Proliferating cell nuclear antigen in oesophageal diseases. Correlation with transforming growth factor α expression
-
Jankowski, J., McMenemin, R., Yu, C., Hopwood, D., and Wormsley, K. G. Proliferating cell nuclear antigen in oesophageal diseases. Correlation with transforming growth factor α expression. Gut, 33: 587-591, 1992.
-
(1992)
Gut
, vol.33
, pp. 587-591
-
-
Jankowski, J.1
McMenemin, R.2
Yu, C.3
Hopwood, D.4
Wormsley, K.G.5
-
48
-
-
0027967896
-
The molecular biology of esophageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes, and growth factors
-
Stemmermann, G., Heffelfinger, S. C., Noffsinger, A., Hui, Y. Z., Miller, M. A., and Fenoglio-Preiser, C. M. The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. Hum. Pathol., 25: 968-981, 1994.
-
(1994)
Hum. Pathol.
, vol.25
, pp. 968-981
-
-
Stemmermann, G.1
Heffelfinger, S.C.2
Noffsinger, A.3
Hui, Y.Z.4
Miller, M.A.5
Fenoglio-Preiser, C.M.6
-
49
-
-
0027016101
-
Epidermal growth factor and its receptor: Marker of - and targets for - chemoprevention of bladder cancer
-
Messing, E. M., and Reznikoff, C. A. Epidermal growth factor and its receptor: marker of - and targets for - chemoprevention of bladder cancer. J. Cell. Biochem., 161: 56-62, 1992.
-
(1992)
J. Cell. Biochem.
, vol.161
, pp. 56-62
-
-
Messing, E.M.1
Reznikoff, C.A.2
-
50
-
-
0027250620
-
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis
-
Rao, J. Y., Hemstreet, G. P., III, Hurst, R. E., Bonner, R. B., Jones, P. L., Min, K. W., and Fradet, Y. Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc. Natl. Acad. Sci. USA, 90: 8287-8291, 1993.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 8287-8291
-
-
Rao, J.Y.1
Hemstreet III, G.P.2
Hurst, R.E.3
Bonner, R.B.4
Jones, P.L.5
Min, K.W.6
Fradet, Y.7
-
51
-
-
0025237455
-
The epidermal growth factor receptor and the prognosis of bladder cancer
-
Phila.
-
Neal. D. R, Sharples, L., Smith, K., Fennelly, J., Hall, R. R., and Harris, A. L. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer (Phila.), 65: 1619-1625, 1990.
-
(1990)
Cancer
, vol.65
, pp. 1619-1625
-
-
Neal, D.R.1
Sharples, L.2
Smith, K.3
Fennelly, J.4
Hall, R.R.5
Harris, A.L.6
-
52
-
-
0028116061
-
Prostate cancer progression. Implications of histopathology
-
Ware, J. L. Prostate cancer progression. Implications of histopathology. Am. J. Pathol., 145: 983-993, 1994.
-
(1994)
Am. J. Pathol.
, vol.145
, pp. 983-993
-
-
Ware, J.L.1
-
53
-
-
0028108003
-
Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue
-
Turkeri, L. N., Sakr, W. A., Wykes, S. M.. Grignon, D. J., Pontes, J. E., and Macoska, J. A. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate, 25: 199-205, 1994.
-
(1994)
Prostate
, vol.25
, pp. 199-205
-
-
Turkeri, L.N.1
Sakr, W.A.2
Wykes, S.M.3
Grignon, D.J.4
Pontes, J.E.5
Macoska, J.A.6
-
54
-
-
0027690442
-
Expression of transforming growth factor-α, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia
-
Myers, R. B., Kudlow, J. E., and Grizzle, W. E. Expression of transforming growth factor-α, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Mod. Pathol., 6: 733-737, 1993.
-
(1993)
Mod. Pathol.
, vol.6
, pp. 733-737
-
-
Myers, R.B.1
Kudlow, J.E.2
Grizzle, W.E.3
-
55
-
-
0026580166
-
Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue
-
Koenders, P. G., Peters, W. H. M., Wobbes, T., Beex, L. V. A. M., Nagengast, F. M., and Bendrad, T. J. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br. J. Cancer, 65: 189-192, 1992.
-
(1992)
Br. J. Cancer
, vol.65
, pp. 189-192
-
-
Koenders, P.G.1
Peters, W.H.M.2
Wobbes, T.3
Beex, L.V.A.M.4
Nagengast, F.M.5
Bendrad, T.J.6
-
56
-
-
0025113702
-
Expression of transforming growth factor-α in primary human colon and lung carcinomas
-
Liu, C., Woo, A., and Tsao, M-S. Expression of transforming growth factor-α in primary human colon and lung carcinomas. Br. J. Cancer, 6: 425-429, 1990.
-
(1990)
Br. J. Cancer
, vol.6
, pp. 425-429
-
-
Liu, C.1
Woo, A.2
Tsao, M.-S.3
-
57
-
-
0026640246
-
Immunoreactive transforming growth factor-α and epidermal growth factor in colorectal adenomas and carcinomas
-
Basel
-
Tanaka, S., Imanishi, K., Haruma, K., Tsuda, T., Yoshihara, M., Sumii, K., and Kajiyama, G. Immunoreactive transforming growth factor-α and epidermal growth factor in colorectal adenomas and carcinomas. Oncology (Basel), 49: 381-385, 1992.
-
(1992)
Oncology
, vol.49
, pp. 381-385
-
-
Tanaka, S.1
Imanishi, K.2
Haruma, K.3
Tsuda, T.4
Yoshihara, M.5
Sumii, K.6
Kajiyama, G.7
-
58
-
-
0025368610
-
Growth stimulation by coexpression of transforming growth factor-α and epidermal growth factor-receptor in normal and adenomatous human colon epithelium
-
Markowitz, S. D., Molkentin, K., Gerbic, C., Jackson, J., Stellato, T., and Wilson, J. K. V. Growth stimulation by coexpression of transforming growth factor-α and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. J. Clin. Invest., 86: 356-362, 1990.
-
(1990)
J. Clin. Invest.
, vol.86
, pp. 356-362
-
-
Markowitz, S.D.1
Molkentin, K.2
Gerbic, C.3
Jackson, J.4
Stellato, T.5
Wilson, J.K.V.6
-
59
-
-
13144286712
-
Bile acids regulate the growth rate of transformed colonie epithelium and increase TGFα mRNA levels in vitro
-
Anderson, B. D., Karnes, W. E., and Pearson, R. K. Bile acids regulate the growth rate of transformed colonie epithelium and increase TGFα mRNA levels in vitro (Abstract). Gastroenterology, 104: A384, 1993.
-
(1993)
Gastroenterology
, vol.104
-
-
Anderson, B.D.1
Karnes, W.E.2
Pearson, R.K.3
-
60
-
-
0026725097
-
Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors
-
Saeki, T., Stromberg, K., Qi, C-F., Gullick, W. J., Tahara, E., Normanno, N., Ciardiello, F., Kenney, N., Johnson, G. R., and Salomon, D. S. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res., 52: 3467-3473, 1992.
-
(1992)
Cancer Res.
, vol.52
, pp. 3467-3473
-
-
Saeki, T.1
Stromberg, K.2
Qi, C.-F.3
Gullick, W.J.4
Tahara, E.5
Normanno, N.6
Ciardiello, F.7
Kenney, N.8
Johnson, G.R.9
Salomon, D.S.10
-
61
-
-
0024359941
-
Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias
-
Goppinger, A., Wittmaack, F. M., Wintzer, H. O., Ikenberg, H., and Bauknecht, T. Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias. J. Cancer Res. Clin. Oncol., 115: 259-263, 1989.
-
(1989)
J. Cancer Res. Clin. Oncol.
, vol.115
, pp. 259-263
-
-
Goppinger, A.1
Wittmaack, F.M.2
Wintzer, H.O.3
Ikenberg, H.4
Bauknecht, T.5
-
62
-
-
0025088557
-
Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia
-
Mittal, K., Pearson, J., and Demopoulos, R. Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia. Gynecol. Oncol., 38: 224-229, 1990.
-
(1990)
Gynecol. Oncol.
, vol.38
, pp. 224-229
-
-
Mittal, K.1
Pearson, J.2
Demopoulos, R.3
-
63
-
-
0026692067
-
Epidermal growth factor receptor expression and the presence of human papilloma virus in cervical squamous intraepithelial lesions
-
Chapman, W. B., Lorincz, A. T., Willett, G. D., Wright, V. C., and Kurman, R. J. Epidermal growth factor receptor expression and the presence of human papilloma virus in cervical squamous intraepithelial lesions. Int. J. Gynecol. Pathol., 11: 221-226, 1992.
-
(1992)
Int. J. Gynecol. Pathol.
, vol.11
, pp. 221-226
-
-
Chapman, W.B.1
Lorincz, A.T.2
Willett, G.D.3
Wright, V.C.4
Kurman, R.J.5
-
64
-
-
0028227225
-
Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix
-
Tervahauta, A., Syrjanen, S., and Syrjanen, K. Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix. Int. J. Gynecol. Pathol., 13: 234-240, 1994.
-
(1994)
Int. J. Gynecol. Pathol.
, vol.13
, pp. 234-240
-
-
Tervahauta, A.1
Syrjanen, S.2
Syrjanen, K.3
-
65
-
-
0029443274
-
Chemoprevention trials in the cervix: Design, feasibility, and recruitment
-
Mitchell, M. F., Hittelman, W. N., Lotan, R., Nishioka, K., Tortolero-Luna, G., Richards-Kortum, R., and Hong, W. K. Chemoprevention trials in the cervix: design, feasibility, and recruitment. J. Cell. Biochem., 23: 104-112, 1995.
-
(1995)
J. Cell. Biochem.
, vol.23
, pp. 104-112
-
-
Mitchell, M.F.1
Hittelman, W.N.2
Lotan, R.3
Nishioka, K.4
Tortolero-Luna, G.5
Richards-Kortum, R.6
Hong, W.K.7
-
66
-
-
0025770820
-
Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues
-
McGlennen, R. C., Ostrow, R. S., Carson, L. F., Stanley, M. S., and Faras, A. J. Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected cervical tissues. Am. J. Obstet. Gynecol., 165: 696-705, 1991.
-
(1991)
Am. J. Obstet. Gynecol.
, vol.165
, pp. 696-705
-
-
McGlennen, R.C.1
Ostrow, R.S.2
Carson, L.F.3
Stanley, M.S.4
Faras, A.J.5
-
67
-
-
0027359405
-
Human papillomavirus 16 immortalization of normal ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression
-
Sizemore, N., and Rorke, E. A. Human papillomavirus 16 immortalization of normal ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res., 53: 4511-4517, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 4511-4517
-
-
Sizemore, N.1
Rorke, E.A.2
-
68
-
-
0028343678
-
Enhancement of regression of cervical intraepithelial neoplasia II (moderated dysplasia) with topically applied all-trans-retinoic acid: A randomized trial
-
Meyskens, F. L., Jr., Surwit, E., Moon, T. E., Childers, J. M., Davis, J. R., Dorr, R. T., Johnson, C. S., and Alberts, D. S. Enhancement of regression of cervical intraepithelial neoplasia II (moderated dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl. Cancer Inst., 86: 539-543, 1994.
-
(1994)
J. Natl. Cancer Inst.
, vol.86
, pp. 539-543
-
-
Meyskens Jr., F.L.1
Surwit, E.2
Moon, T.E.3
Childers, J.M.4
Davis, J.R.5
Dorr, R.T.6
Johnson, C.S.7
Alberts, D.S.8
-
69
-
-
0026571910
-
The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients
-
Klijn, J. G. M., Berns, P. M. J. J., Schmitz, P. I. M., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev., 13: 3-17, 1992.
-
(1992)
Endocr. Rev.
, vol.13
, pp. 3-17
-
-
Klijn, J.G.M.1
Berns, P.M.J.J.2
Schmitz, P.I.M.3
Foekens, J.A.4
-
70
-
-
0029043609
-
Growth factor synthesis and human breast cancer progression
-
Ethier, S. P. Growth factor synthesis and human breast cancer progression. J. Natl. Cancer Inst., 87: 964-973, 1995.
-
(1995)
J. Natl. Cancer Inst.
, vol.87
, pp. 964-973
-
-
Ethier, S.P.1
-
71
-
-
0028223731
-
Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry
-
van Agthoven, T., Timmermans, M., Foekens, J. A., Dorssers, L. C. J., and Henzen-Logmans, S. C. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am. J. Pathol., 144: 1238-1246, 1994.
-
(1994)
Am. J. Pathol.
, vol.144
, pp. 1238-1246
-
-
Van Agthoven, T.1
Timmermans, M.2
Foekens, J.A.3
Dorssers, L.C.J.4
Henzen-Logmans, S.C.5
-
72
-
-
0027930238
-
Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer
-
Fabian, C. J., Zalles, C, Kamel, S., Kimler, B. F., McKittrick, R., Tranin, A. S., Zeiger, S., Moore, W. P., Hassanein, R. S., Simon, C., Johnson, N., Vergara, G., Jewell, W. R., Lin, F., Bhatia, P., and Chin, T. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer. Breast Cancer Res. Treat., 30: 263-274, 1994.
-
(1994)
Breast Cancer Res. Treat.
, vol.30
, pp. 263-274
-
-
Fabian, C.J.1
Zalles, C.2
Kamel, S.3
Kimler, B.F.4
McKittrick, R.5
Tranin, A.S.6
Zeiger, S.7
Moore, W.P.8
Hassanein, R.S.9
Simon, C.10
Johnson, N.11
Vergara, G.12
Jewell, W.R.13
Lin, F.14
Bhatia, P.15
Chin, T.16
-
73
-
-
0002020447
-
Cellular biology and biochemistry of the retinoids
-
M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), Chap. 11, New York: Raven Press, Ltd.
-
Gudas, L. J., Sporn, M. B., and Roberts, A. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, Ed. 2, Chap. 11, pp. 443-520. New York: Raven Press, Ltd., 1994.
-
(1994)
The Retinoids: Biology, Chemistry, and Medicine, Ed. 2
, pp. 443-520
-
-
Gudas, L.J.1
Sporn, M.B.2
Roberts, A.B.3
-
74
-
-
0021363327
-
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies
-
Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 44: 1002-1007, 1984.
-
(1984)
Cancer Res.
, vol.44
, pp. 1002-1007
-
-
Masui, H.1
Kawamoto, T.2
Sato, J.D.3
Wolf, B.4
Sato, G.5
Mendelsohn, J.6
-
75
-
-
0028067658
-
Quercetin in our diet: From potent mutagen to probable anticarcinogen
-
Stavric, B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin. Biochem., 27: 245-248, 1994.
-
(1994)
Clin. Biochem.
, vol.27
, pp. 245-248
-
-
Stavric, B.1
-
76
-
-
0026458235
-
Tyrphostins: Tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction
-
Levitzki, A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J., 6: 3275-3282, 1992.
-
(1992)
FASEB J.
, vol.6
, pp. 3275-3282
-
-
Levitzki, A.1
-
77
-
-
0028172837
-
Tyrosine protein kinase inhibition and cancer
-
Boulin, J. A. Tyrosine protein kinase inhibition and cancer. Int. J. Biochem., 26: 1203-1226, 1994.
-
(1994)
Int. J. Biochem.
, vol.26
, pp. 1203-1226
-
-
Boulin, J.A.1
-
78
-
-
0028910254
-
Biochemical targets of the isoflavone genistein in tumor cell lines
-
Barnes, S., and Peterson, T. G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med., 208: 103-108, 1995.
-
(1995)
Proc. Soc. Exp. Biol. Med.
, vol.208
, pp. 103-108
-
-
Barnes, S.1
Peterson, T.G.2
-
79
-
-
0027183968
-
Integrated system for the screening of the specificity of protein kinase inhibitors
-
Barret, J. M., Ernould, A. P., Ferry, G., Genton, A., and Boutin, J. A. Integrated system for the screening of the specificity of protein kinase inhibitors. Biochem. Pharmacol., 46: 439-448, 1993.
-
(1993)
Biochem. Pharmacol.
, vol.46
, pp. 439-448
-
-
Barret, J.M.1
Ernould, A.P.2
Ferry, G.3
Genton, A.4
Boutin, J.A.5
-
80
-
-
0027198702
-
Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins
-
Osherov, N., Gazit, A., Gilon, C., and Levitzki, A. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J. Biol. Chem., 268: 11134-11142, 1993.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 11134-11142
-
-
Osherov, N.1
Gazit, A.2
Gilon, C.3
Levitzki, A.4
-
81
-
-
0003060912
-
Retinoids and cancer in experimental animals
-
M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), Chap. 14, New York: Raven Press, Ltd.
-
Moon, R. C., Mehta, R. G., and Rao, K. V. N. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, Ed. 2, Chap. 14, pp. 573-595. New York: Raven Press, Ltd., 1994.
-
(1994)
The Retinoids: Biology, Chemistry, and Medicine, Ed. 2
, pp. 573-595
-
-
Moon, R.C.1
Mehta, R.G.2
Rao, K.V.N.3
-
82
-
-
0027131289
-
Tyrphostins. 3. Structure-activity relationship studies of α-substituted benzylidenemalononitrile 5-S-aryltyrphostins
-
Gazit, A., Osherov, N., Posner, I., Bar-Sinai, A., Gilon, C., and Levitzki, A. Tyrphostins. 3. Structure-activity relationship studies of α-substituted benzylidenemalononitrile 5-S-aryltyrphostins. J. Med. Chem., 36: 3556-3564, 1993.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 3556-3564
-
-
Gazit, A.1
Osherov, N.2
Posner, I.3
Bar-Sinai, A.4
Gilon, C.5
Levitzki, A.6
-
83
-
-
0028922430
-
Tyrphostins suppress the growth of psoriatic keratinocytes
-
Ben-Bassat, H., Vardi, D. V., Gazit, A., Klaus, S. N., Chaouat, M., Hartzstark, Z., and Levitzki, A. Tyrphostins suppress the growth of psoriatic keratinocytes. Exp. Dermatol., 4: 82-88, 1995.
-
(1995)
Exp. Dermatol.
, vol.4
, pp. 82-88
-
-
Ben-Bassat, H.1
Vardi, D.V.2
Gazit, A.3
Klaus, S.N.4
Chaouat, M.5
Hartzstark, Z.6
Levitzki, A.7
-
84
-
-
0025988512
-
The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice
-
Yoneda, T., Lyall, R. M., Alsina, M. M., Persons, P. E., Spada, A. P., Levitzki, A., Zilberstein, A., and Mundy, G. R. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res., 51: 4430-4435, 1991.
-
(1991)
Cancer Res.
, vol.51
, pp. 4430-4435
-
-
Yoneda, T.1
Lyall, R.M.2
Alsina, M.M.3
Persons, P.E.4
Spada, A.P.5
Levitzki, A.6
Zilberstein, A.7
Mundy, G.R.8
-
85
-
-
0028355561
-
Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration of dermal application
-
Khetarpal, V. K., Markham, P. M., and Ziemniak, J. A. Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration of dermal application. Drug Metab. Dispos., 22: 216-223, 1994.
-
(1994)
Drug Metab. Dispos.
, vol.22
, pp. 216-223
-
-
Khetarpal, V.K.1
Markham, P.M.2
Ziemniak, J.A.3
-
86
-
-
0026747795
-
Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor
-
Reddy, K. B., Mangold, G. L., Tandon, A. K., Yoneda, T., Mundy, G. R., Zilberstein, A., and Osborne, C. K. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. Cancer Res., 52: 3636-3641, 1992.
-
(1992)
Cancer Res.
, vol.52
, pp. 3636-3641
-
-
Reddy, K.B.1
Mangold, G.L.2
Tandon, A.K.3
Yoneda, T.4
Mundy, G.R.5
Zilberstein, A.6
Osborne, C.K.7
-
87
-
-
0028180234
-
4,5-Dianilinophthalimide: A protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity
-
Buchdunger, E., Trinks, U., Mett, H., Regenass, U., Muller, M., Meyer, T., McGlynn, E., Pinna, L. A., Traxler, P., and Lydon, N. B. 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc. Natl. Acad. Sci. USA, 91: 2334-2338, 1994.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 2334-2338
-
-
Buchdunger, E.1
Trinks, U.2
Mett, H.3
Regenass, U.4
Muller, M.5
Meyer, T.6
McGlynn, E.7
Pinna, L.A.8
Traxler, P.9
Lydon, N.B.10
-
88
-
-
0028978269
-
4,5-bis(Fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity
-
Buchdunger, E., Mett, H., Trinks, U., Regenass, U., Muller, M., Meyer, T., Beilstein, P., Wirz, B., Schneider, P., Traxler, P., and Lydon, N. B. 4,5-bis(Fluoroanilino)phthalimide: a selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity. Clin. Cancer Res., 1: 813-821, 1995.
-
(1995)
Clin. Cancer Res.
, vol.1
, pp. 813-821
-
-
Buchdunger, E.1
Mett, H.2
Trinks, U.3
Regenass, U.4
Muller, M.5
Meyer, T.6
Beilstein, P.7
Wirz, B.8
Schneider, P.9
Traxler, P.10
Lydon, N.B.11
-
89
-
-
0028142387
-
A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
-
Washington DC
-
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Washington DC), 265: 1093-1095, 1994.
-
(1994)
Science
, vol.265
, pp. 1093-1095
-
-
Fry, D.W.1
Kraker, A.J.2
McMichael, A.3
Ambroso, L.A.4
Nelson, J.M.5
Leopold, W.R.6
Connors, R.W.7
Bridges, A.J.8
-
90
-
-
9844249283
-
Epidermal growth factor receptor tyrosine kinase in A431 xenografts: Inhibition by PD 153035 [4-(3-bromoanilino)-6,7-dimethoxyquinazoline]
-
Hook, K. E., Kunkel, M. W., Elliot, W. L., Howard, C. T., and Leopold, W. R. Epidermal growth factor receptor tyrosine kinase in A431 xenografts: inhibition by PD 153035 [4-(3-bromoanilino)-6,7-dimethoxyquinazoline]. Proc. Am. Assoc. Cancer Res., 36: 434, 1995.
-
(1995)
Proc. Am. Assoc. Cancer Res.
, vol.36
, pp. 434
-
-
Hook, K.E.1
Kunkel, M.W.2
Elliot, W.L.3
Howard, C.T.4
Leopold, W.R.5
-
91
-
-
0029130763
-
Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5′-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor
-
Rewcastle, G. W., Denny, W. A., Bridges, A. J., Zhou, H., Cody, D. R., McMichael, A., and Fry, D. W. Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5′-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. J. Med. Chem., 38: 3482-3487, 1995.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 3482-3487
-
-
Rewcastle, G.W.1
Denny, W.A.2
Bridges, A.J.3
Zhou, H.4
Cody, D.R.5
McMichael, A.6
Fry, D.W.7
-
92
-
-
0028106163
-
Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor
-
Ward, W. H. J., Cook, P. N., Slater, A. M., Davies, D. H., Holdgate, G. A., and Green, L. R. Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem. Pharmacol., 48: 659-666, 1994.
-
(1994)
Biochem. Pharmacol.
, vol.48
, pp. 659-666
-
-
Ward, W.H.J.1
Cook, P.N.2
Slater, A.M.3
Davies, D.H.4
Holdgate, G.A.5
Green, L.R.6
-
93
-
-
15844427666
-
-
European Patent 520,722, December 30, 1992
-
Barker, A. J., Davies, D. H. (inventors), and Imperial Chemical Industries. PLC (assignee). Pharmaceutical composition comprising quinazoline derivatives inhibit receptor tyrosine kinase(s) and are used for treating cancers e.g., leukemia(s) and tumors of breast, lung, colon, and rectum. European Patent 520,722, December 30, 1992.
-
Pharmaceutical Composition Comprising Quinazoline Derivatives Inhibit Receptor Tyrosine Kinase(s) and Are Used for Treating Cancers e.g., Leukemia(s) and Tumors of Breast, Lung, Colon, and Rectum
-
-
Barker, A.J.1
Davies, D.H.2
-
94
-
-
0029123125
-
Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: A new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor
-
Thompson, A. M., Bridges, A. J., Fry, D. W., Kraker, A. J., and Denny, W. A. Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. J. Med. Chem., 38: 3780-3786, 1995.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 3780-3786
-
-
Thompson, A.M.1
Bridges, A.J.2
Fry, D.W.3
Kraker, A.J.4
Denny, W.A.5
-
95
-
-
0029034741
-
[(Alkylamino)methyl]acrylophenones: Potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase
-
Traxler, P., Trinks, U., Buchdunger, E., Mett, H., Meyer, T., Muller, M, Regenass, U., Rosel, J., and Lydon, N. [(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase. J. Med. Chem., 38: 2441-2448, 1995.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 2441-2448
-
-
Traxler, P.1
Trinks, U.2
Buchdunger, E.3
Mett, H.4
Meyer, T.5
Muller, M.6
Regenass, U.7
Rosel, J.8
Lydon, N.9
-
96
-
-
0028323606
-
BE-23372M, a novel and specific inhibitor, for epidermal growth factor receptor kinase
-
Tanaka, S., Okabe, T., Chieda, S., Endo, K., Kanoh, T., Okura, A., and Yoshida, E. BE-23372M, a novel and specific inhibitor, for epidermal growth factor receptor kinase. Jpn. J. Cancer Res., 55: 253-259, 1994.
-
(1994)
Jpn. J. Cancer Res.
, vol.55
, pp. 253-259
-
-
Tanaka, S.1
Okabe, T.2
Chieda, S.3
Endo, K.4
Kanoh, T.5
Okura, A.6
Yoshida, E.7
-
97
-
-
0028328248
-
Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: Importance of additional hydrophobic aromatic interactions
-
Chen, H., Boiziau, J., Parker, F., Mailliet, P., Commercon, A., Tocque, B., Le Pecq, J-B., Roques, B-P., and Garbay, C. Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions. J. Med. Chem., 37: 845-859, 1994.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 845-859
-
-
Chen, H.1
Boiziau, J.2
Parker, F.3
Mailliet, P.4
Commercon, A.5
Tocque, B.6
Le Pecq, J.-B.7
Roques, B.-P.8
Garbay, C.9
-
98
-
-
0028049743
-
Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity
-
Fry, D. W., Kraker, A. J., Connors, R. C., Elliott, W. L., Nelson, J. M., Showalter, H. D. H., and Leopold, W. R. Strategies for the discovery of novel tyrosine kinase inhibitors with anticancer activity. Anti-Cancer Drug Des., 9: 331-351, 1994.
-
(1994)
Anti-Cancer Drug Des.
, vol.9
, pp. 331-351
-
-
Fry, D.W.1
Kraker, A.J.2
Connors, R.C.3
Elliott, W.L.4
Nelson, J.M.5
Showalter, H.D.H.6
Leopold, W.R.7
-
99
-
-
0027185402
-
Tyrosine kinase inhibitors. I. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2′-dithiobis(1H-indole-3-alkanoic acids)
-
Thompson, A. M., Rewcastle, G. W., Tercel, M., Dobrusin, E. M., Fry, D. W., Kraker, A. J., and Denny, W. A. Tyrosine kinase inhibitors. I. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2′-dithiobis(1H-indole-3-alkanoic acids). J. Med. Chem., 36: 2459-2469, 1993.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 2459-2469
-
-
Thompson, A.M.1
Rewcastle, G.W.2
Tercel, M.3
Dobrusin, E.M.4
Fry, D.W.5
Kraker, A.J.6
Denny, W.A.7
-
100
-
-
0029035467
-
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2′-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases
-
Palmer, B. D., Rewcastle, G. W., Thompson, A. M., Boyd, M., Showalter, H. D. H., Sercel, A. D., Fry, D. W., Kraker, A. J., and Denny, W. A. Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2′-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinases. J. Med. Chem., 38: 58-67, 1995.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 58-67
-
-
Palmer, B.D.1
Rewcastle, G.W.2
Thompson, A.M.3
Boyd, M.4
Showalter, H.D.H.5
Sercel, A.D.6
Fry, D.W.7
Kraker, A.J.8
Denny, W.A.9
-
101
-
-
0028104631
-
Synthesis and biochemical evaluation of a series of aminoflavones as potential inhibitors of protein-tyrosine kinases p56lck, EGFr, and p60v-src
-
Cushman, M., Zhu, H., Geahlen, R. L., and Kraker, A. J. Synthesis and biochemical evaluation of a series of aminoflavones as potential inhibitors of protein-tyrosine kinases p56lck, EGFr, and p60v-src. J. Med. Chem., 37: 3353-3362, 1994.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3353-3362
-
-
Cushman, M.1
Zhu, H.2
Geahlen, R.L.3
Kraker, A.J.4
-
102
-
-
37049084662
-
Potential mechanism-based tyrosine kinase inhibitors. Part 2. Design and synthesis of peptides containing heterocyclic tyrosine analogues
-
Andrews, D. M., Gregoriou, M, Page, T. C. M., Peach, J. M., and Pratt, A. J. Potential mechanism-based tyrosine kinase inhibitors. Part 2. Design and synthesis of peptides containing heterocyclic tyrosine analogues. J. Chem. Soc. Perkin Trans. I, 11: 1335-1340, 1995.
-
(1995)
J. Chem. Soc. Perkin Trans. I
, vol.11
, pp. 1335-1340
-
-
Andrews, D.M.1
Gregoriou, M.2
Page, T.C.M.3
Peach, J.M.4
Pratt, A.J.5
-
103
-
-
0027176674
-
The hamster cheek pouch carcinogenesis model
-
Gimenez-Conti, I. B., and Slaga, T. J. The hamster cheek pouch carcinogenesis model. J. Cell. Biochem., 17F: 83-90, 1993.
-
(1993)
J. Cell. Biochem.
, vol.17 F
, pp. 83-90
-
-
Gimenez-Conti, I.B.1
Slaga, T.J.2
-
104
-
-
0025261739
-
Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxyase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model
-
Shin, D. M., Gimenez, I. B., Lee, J. S., Nishioka, K., Wargovich, M. J., Thacher, S., Lotan, R., Slaga, T. J., and Hong, W. K. Expression of epidermal growth factor receptor, polyamine levels, ornithine decarboxyase activity, micronuclei, and transglutaminase I in a 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model. Cancer Res., 50: 2505-2510, 1990.
-
(1990)
Cancer Res.
, vol.50
, pp. 2505-2510
-
-
Shin, D.M.1
Gimenez, I.B.2
Lee, J.S.3
Nishioka, K.4
Wargovich, M.J.5
Thacher, S.6
Lotan, R.7
Slaga, T.J.8
Hong, W.K.9
-
105
-
-
0028658301
-
Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention testing program
-
Steele, V. E., Moon, R. C., Lubet, R. A., Grubbs, C. J., Reddy, B. S., Wargovich, M., McCormick, D. L., Pereira, M. A., Crowell, J. A., Bagheri, D., Sigman, C. C., Boone, C. W., and Kelloff, G. J. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention testing program. J. Cell. Biochem. Suppl., 20: 32-54, 1994.
-
(1994)
J. Cell. Biochem. Suppl.
, vol.20
, pp. 32-54
-
-
Steele, V.E.1
Moon, R.C.2
Lubet, R.A.3
Grubbs, C.J.4
Reddy, B.S.5
Wargovich, M.6
McCormick, D.L.7
Pereira, M.A.8
Crowell, J.A.9
Bagheri, D.10
Sigman, C.C.11
Boone, C.W.12
Kelloff, G.J.13
-
106
-
-
0028032074
-
Protein-tyrosine kinases: Potential targets for anticancer drug development
-
Burke, T. R., Jr. Protein-tyrosine kinases: potential targets for anticancer drug development. Stem Cells, 12: 1-6, 1994.
-
(1994)
Stem Cells
, vol.12
, pp. 1-6
-
-
Burke Jr., T.R.1
-
107
-
-
0028582185
-
Crystal structure of the tyrosine kinase domain of the human insulin receptor
-
Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W. A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (Lond.), 372: 746-754, 1994.
-
(1994)
Nature (Lond.)
, vol.372
, pp. 746-754
-
-
Hubbard, S.R.1
Wei, L.2
Ellis, L.3
Hendrickson, W.A.4
-
108
-
-
0027319145
-
Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor
-
Knighton, D. R., Cadena, D. L., Zheng, J., Ten Eyck, L. F., Taylor, S. S., Sowadski, J. M., and Gill, G. N. Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA, 90: 5001-5005, 1993.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 5001-5005
-
-
Knighton, D.R.1
Cadena, D.L.2
Zheng, J.3
Ten Eyck, L.F.4
Taylor, S.S.5
Sowadski, J.M.6
Gill, G.N.7
|